CA2087979A1 - Inhibition par l'interleukine 8 du degagement d'histamine par des basophiles et des mastocytes, induit par des cytokinines - Google Patents

Inhibition par l'interleukine 8 du degagement d'histamine par des basophiles et des mastocytes, induit par des cytokinines

Info

Publication number
CA2087979A1
CA2087979A1 CA002087979A CA2087979A CA2087979A1 CA 2087979 A1 CA2087979 A1 CA 2087979A1 CA 002087979 A CA002087979 A CA 002087979A CA 2087979 A CA2087979 A CA 2087979A CA 2087979 A1 CA2087979 A1 CA 2087979A1
Authority
CA
Canada
Prior art keywords
allergic
cells
hrf
histamine release
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002087979A
Other languages
English (en)
Inventor
Rafeul Alam
Michael A. Lett-Brown
J. Andrew Grant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2087979A1 publication Critical patent/CA2087979A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002087979A 1990-07-25 1991-07-25 Inhibition par l'interleukine 8 du degagement d'histamine par des basophiles et des mastocytes, induit par des cytokinines Abandoned CA2087979A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55800490A 1990-07-25 1990-07-25
US558,004 1990-07-25

Publications (1)

Publication Number Publication Date
CA2087979A1 true CA2087979A1 (fr) 1992-01-26

Family

ID=24227761

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087979A Abandoned CA2087979A1 (fr) 1990-07-25 1991-07-25 Inhibition par l'interleukine 8 du degagement d'histamine par des basophiles et des mastocytes, induit par des cytokinines

Country Status (5)

Country Link
EP (1) EP0540663A1 (fr)
JP (1) JPH06502396A (fr)
AU (1) AU661461B2 (fr)
CA (1) CA2087979A1 (fr)
WO (1) WO1992001465A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554590A (en) * 1992-08-19 1996-09-10 East Carolina University Method of treating asthma
US5436222A (en) * 1993-03-15 1995-07-25 The Research Foundation Of State University Of New York Use of platelet factor 4 to treat inflammatory diseases
US5474983A (en) * 1993-03-15 1995-12-12 The Research Foundation Of State University Of New York Method of inhibiting pro-inflammatory mediator release from basophils and mast cells
US6520173B2 (en) * 2000-05-02 2003-02-18 Robert Martin Lautner Portable solid-fuel camp-stove
JP4571952B2 (ja) * 2004-02-05 2010-10-27 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 抗アレルギー組成物及び関連方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926743T2 (de) * 1988-01-12 1997-01-09 Univ Texas Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
AU2348492A (en) * 1991-07-19 1993-02-23 East Carolina University Method of treating asthma

Also Published As

Publication number Publication date
AU661461B2 (en) 1995-07-27
AU8412491A (en) 1992-02-18
JPH06502396A (ja) 1994-03-17
EP0540663A1 (fr) 1993-05-12
WO1992001465A1 (fr) 1992-02-06

Similar Documents

Publication Publication Date Title
Alam et al. Macrophage inflammatory protein-1 alpha activates basophils and mast cells.
Alam et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
Proost et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
Sim et al. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment.
Kaplan Chemokines, chemokine receptors and allergy
Ochensberger et al. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists
Alam et al. Comparative effect of recombinant IL-1,-2,-3,-4, and-6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils.
Cher et al. Molecular basis of cardiotoxicity upon cobra envenomation
Hoffman et al. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms
CA2114016A1 (fr) Methodes et compositions modulatrices de l'action de la proteine g
EP1439231B1 (fr) Amino-terminale tronquée c-c chemokine et d'un antagoniste de chemokine
EP0504257A1 (fr) FACTEUR POLYPEPTIDIQUE [Ala IL-8] 77 UTILISE COMME INIHIBITEUR D'ADHESION DES LEUCOCYTES
CA2087979A1 (fr) Inhibition par l'interleukine 8 du degagement d'histamine par des basophiles et des mastocytes, induit par des cytokinines
Hartmann et al. Effect of CC chemokines on mediator release from human skin mast cells and basophils
Reddigari et al. Connective tissue—activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils
US20040229795A1 (en) Use of antithrombin III for the prophylaxis and therapy of diseases
Abdel-Haleem et al. Serum levels of IL-6 and its soluble receptor, TNF-α and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome
WO1994007521A1 (fr) Procedes et compositions de traitement de maladies allergiques
Kramer et al. Nasal IL-16 and MIP-1 [alpha] in Late-Phase Allergic Response
KR102010436B1 (ko) 신규 알러지 반응 검사용 조성물
van den Blink et al. P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia
EP0398924B1 (fr) Facteur inhibitant la liberation d'histamine et preparations le contenant
WO1990005537A1 (fr) Inhib, un facteur qui inhibe les leukocytes actives par la cytokine
Kaplan et al. Chemokines and the late-phase reaction.
US5322838A (en) Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation

Legal Events

Date Code Title Description
FZDE Dead